Xipamide (Diurexan) and indapamide (Natrilix) have been introduced as new antihypertensive agents. They are marketed as being more effective than the thiazide diuretics but not as potent as beta-blockers. They are both thiazide-related, being chemically similar to chlorthalidone. It is claimed that they lower blood pressure without causing an appreciable diuresis, and that the incidence of hypokalaemia in hypertensive patients is much lower than with the other thiazide diuretics. Thus many patients have been started on treatment with one of these two drugs, and they are especially popular with general practitioners because the regimen is one tablet a day.1 2 Patients who are referred to our outpatient department or who come as inpatients taking these drugs are frequently severely hypokalaemic and moreover are symptomatically so.
Case report
On 26 August 1981 a woman aged 64 was brought to the accident centre having collapsed. She was semiconscious and had multifocal ectopic beats with short runs of ventricular tachycardia. Before any treatment could be started she developed ventricular fibrillation, which immediately responded to a DC shock of 200 joules. She continued to have an alarming number of multifocal ventricular ectopic beats, and her mental state remained unchanged. She was started on maximal doses of lignocaine. After she was admitted to the cardiac care unit it was discovered that her general practitioner had been treating her for hypertension since February with xipamide 20 mg per day. During the week before admission she had become increasingly unwell, with generalised weakness and muscle pains and had seen her general practitioner the day before.
On admission her plasma potassium concentration was 1-2 mmol(mEq)/l, with a bicarbonate of more than 40 mmol (mEq)/l. She was very confused and restless after defibrillation and was started on 80 mmol of potassium per hour intravenously and the electrolyte concentration estimated hourly. In one hour the multifocal ectopics had completely disappeared, and she remained in sinus rhythm thereafter. She remained severely hypokalaemic, however, and required a total of 760 mmol of potassium intravenously in the first 24 hours. The plasma potassium concentration then rose to 4-4 mmol, and her mental state returned to normal. Intravenous treatment was stopped, but her plasma potassium concentration dropped again to 2-4 mmol(mEq)/l, and she was started on oral supplements of 36 mmol per day as effervescent potassium tablets. After two days her plasma potassium concentration had once more returned to normal, and her electrolytes subsequently have Southend Hospital, Essex SSO ORY PAUL ALTMANN, medical registrar J J HAMBLIN, FRCP, consultant physician Any diuretic, unless specifically a potassiumsparing one, may cause profound hypokalaemia remained normal. Her progress was complicated by a chest infection, but she is now well and continues to attend for follow-up.
Discussion
Xipamide and indapamide should not cause such profound problems, according to the manufacturers.3 The results of studies of the treatment of hypertension with these two drugs have shown that plasma potassium concentrations remained well within the normal range, even without supplementation, or that at the usual dose for hypertension potassium supplementation would not normally be an essential part of treatment5-7; and "side effects have not been a problem with xipamide administration."' Nevertheless, other studies have shown the equipotency of xipamide as compared to other diuretics such as frusemide and chlorthalidone,9 and one such study showed that "potassium excretion was greater following xipamide in the dose of 40 mg than after 50 mg of hydrochlorthiazide, the difference being statistically significant" (F Kruck, data files, E Merck Ltd). Thus, the findings on the subject seem to be contradictory.
We feel strongly that neither xipamide nor indapamide should be marketed as hypotensive diuretics that do not require potassium supplements. These drugs are potent diuretics.
